MRI study on reversible and irreversible electroporation induced blood brain barrier disruption

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hjouj, Mohammad ^a   Last, David ^b   Guez, David ^b   Daniels, Dianne ^b   Sharabi, Shirley ^b   Lavee, Jacob ^b   Rubinsky, Boris ^d   Mardor, Yael ^b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; TETRAXETAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN SIZE; BRAIN TISSUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ELECTROPORATION; FEASIBILITY STUDY; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RAT; TISSUE INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; ELECTROPORATION; MAGNETIC RESONANCE IMAGING; MALE; RATS;

RATTUS;

EID: 84866613762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042817     Document Type: Article

References (48)

1. Weaver JC, (2000) Electroporation of cells and tissues. IEEE Trans Plasma 28:: 24--33.
2. Weaver JC, Chizmadzhev YA, (1996) Theory of electroporation: a review. Bioelectrochemistry and Bioenergetics 41:: 135--160.
3. Pakhomov AG, Miklavcic D, Markov MS (2010) Advanced electroporation techniques in biology and medicine. New York: CRC Press.
4. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH, (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 7:: 841--845.
5. Davalos RV, Mir IL, Rubinsky B, (2005) Tissue ablation with irrrevesible electroporation. Ann Biomed Eng 33:: 223--231.
6. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B, (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:: 1409--1415.
7. Al-Sakere B, André F, Bernat C, Connault E, Opolon P, et al. (2007) Tumor ablation with irreversible electroporation. PLoS One 2:: e1135.
8. Rubinsky B, Onik G, Mikus P, (2007) Irreversible electroporation: A new ablation modality - clinical implications. Technol Cancer Res Treat 6:: 37--48.
9. Ball C, Thomson KR, Kavnoudias H, (2010) Irreversible electroporation: A new challenge in "out of operating theatre" anesthesia. Anesth and Analg 110:: 1305--1309.
10. Thomson K (2010) Human experience with irreversible electroporation. Berlin Heidelberg, Springer Press.
11. Bagla S, Papadouris D, (2012) Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: a case report. J Vasc Interv Radiol 23:: 142--145.
12. Maor E, Ivorra A, Leor J, Rubinsky B, (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:: 307--312.
13. Onik G, Mikus P, Rubinsky B, (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6:: 295--300.
14. Phillips M, Maor E, Rubinsky B, (2010) Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng 132:: 091003.
15. Phillips MA, Narayan R, Padath T, Rubinsky B, (2012) Irreversible electroporation on the small intestine. Br J Cancer 106:: 490--495.
16. Garcia PA, Rossmeisl JH Jr, Neal RE 2nd, Ellis TL, Olson JD, et al (2010) Intracranial nonthermal irreversible electroporation: in vivo analysis. J Membr Biol 236:: 127--136.
17. Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, et al. (2011) Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation. J Neurosurg 114:: 681--688.
18. Neal RE 2nd, Rossmeisl JH Jr, Garcia PA, Lanz OI, Henao-Guerrero N, et al (2011) Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 29:: e372--e377.
19. Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, et al. (2001) Monitoring response to convention-enhanced taxol delivery in brain tumer patients using diffusion-weighted magnetic resonance imaging. Cancer Res 61:: 4971--4973.
20. Mardor Y, Rahav O, Zauberman Y, Lidar Z, Ocherashvilli A, et al. (2005) Convection-enhanced drug delivery: Increased efficacy and magnetic resonance image monitoring. Cancer Res 65:: 6858--6863.
21. Serša G, Beravs K, Čemažar M, Miklavčič D, Demšar F, et al. (1998) Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro- and magnetobiology 17:: 299--306.
22. Hannig J, Kovar DA, Abramov GS, Zhang D, Zamora M, et al. (1999) Contrast enhanced MRI of electroporation injury. Proceedings of The First Joint BMES/EMBS Conference.
23. Simon JH, Li D, Traboulsee A, Coyle PK, Arnold DL, et al. (2006) Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines. Am J Neuroradiol 27:: 455--461.
24. Mikulis DJ, Roberts TP, (2007) Neuro MR: Protocols. J Magn Res Imaging 26:: 838--847.
25. Runge VM, Carollo BR, Wolf CR, Nelson KL, Gelblum DY, (1898) Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging. Radiographics 9:: 929--958.
26. Filippi M, Horsfield MA, Hajnal JV, Narayana PA, Udupa JK, et al. (1998) Quantitative assessment of magnetic resonance imaging lesion load in multiple sclerosis. J Neurol Neurosurg Psychiatry (Suppl 1): S88-S93.
27. Runge VM, (1995) The use of MR contrast in nonneoplastic disease of the brain. Top Magn Reson Imaging 7:: 158--167.
28. Rosman Y, Eisenkraft A, Krivoy A, Schein O, Makarovski I, et al. (2012) Using MRI for the assessment of paraoxon-induced brain damage and efficacy of antidotal treatment. J Appl Toxicol 32:: 409--416.
29. Byrnes KR, Loane DJ, Stoica BA, Zhang J, Faden AI, (2012) Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation 9:: 43.
30. Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, et al. (2012) Multiple sclerosis lesions and irreversible brain tissue damage: A comparative ultrahigh-field strength magnetic resonance imaging study. Arch Neurol [Epub ahead of print].
31. Ghosh N, Recker R, Shah A, Bhanu B, Ashwal S, et al. (2011) Automated ischemic lesion detection in a neonatal model of hypoxic ischemic injury. J Magn Reson Imaging. 33:: 772--781.
32. Mir L (2006) Bases and rationale of the electrochemotherapy. Europ J Cancer Suppl 4: 38-44.
33. Dev SB, Caban JB, Nanda GS, Bleecher SD, Rabussay DP, et al. (2002) Magnetic resonance studies of laryngeal tumors implanted in nude mice: effect of treatment with bleomycin and electroporation. Magn Reson Imaging 20:: 389--394.
34. Heller LC, Heller R, (2006) In vivo electroporation for gene therapy. Hum Gene Ther 17:: 890--897.
35. Leroy-Willig A, Bureau MF, Scherman D, Carlier PG, (2005) In vivo NMR imaging evaluation of efficiency and toxicity of gene electrotransfer in rat muscle. Gene Ther 12:: 1434--1443.
36. Bureau MF, Jugé L, Seguin J, Rager MN, Scherman D, et al. (2010) Muscle transfection and permeabilization induced by electrotransfer or pluronic L64 Paired study by optical imaging and MRI. Biochim Biophys Acta 1800:: 537--543.
37. Aung W, Hasegawa S, Koshikawa-Yano M, Obata T, Ikehira H, et al. (2009) Visualization of in vivo electroporation mediated transgene exression in experimental tumors by optical and magnetic resonance imaging. Gene Ther 16:: 830--839.
38. Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, et al. (2010) MR imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: preclinical feasibility studies in a rodent model. Radiology 256:: 424--432.
39. Hjouj M, Rubinsky B, (2010) Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue. J Membr Biol 236:: 137--146.
40. Mahmood F, Hansen RH, Agerholm-Larsen B, Jensen KS, Iversen HK, et al. (2011) Diffusion-weighted MRI for verification of electroporation-based treatments. J Membr Biol 240:: 131--138.
41. Hjouj M, Last D, Guez D, Daniels D, Lavee J, et al. (2011) Electroporation induced BBB disruption and tissue damage depicted by MRI. Neurooncol 13: Issue suppl 3, abstract ET-32.
42. Maor E, Rubinsky B, (2010) Endovascular nonthermal irreversible electroporation: a finite element analysis. J Biomech Eng 132:: 031008.
43. Ivorra A, Rubinsky B, (2006) In vivo electrical impedance measurements during and after electroporation of rat liver. Bioelectrochem 70:: 287--295.
44. Hawkins BT, Davis TP, (2005) The blood-brain barrier/Neurovascualr unit in health and disease. Pharmacol Rev 57:: 173--185.
45. McDannold N, Vykhodtseva N, Hynynen K, (2007) Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34:: 834--840.
46. Silva GA, (2008) Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neurosci 9 Suppl 3: S4.
47. Brigger I, Morizet J, Aubert G, Chacun H, Terrier-Lacombe MJ, et al. (2002) Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Phamacol Exp Ther 303:: 928--936.
48. Lopez-Quintero SV, Datta A, Amaya R, Elwassif M, Bikson M, et al. (2010) DBS-relevant electric fields increase hydraulic conductivity of in vitro endothelial monolayers. J Neural Eng 7:: 16005.